Background: Postoperative complication rates in patients with inflammatory bowel disease (IBD) receiving preoperative biologics have been analyzed without considering the surgical context. Emergency surgery may be associated with an increased risk of infectious complications, compared to elective operations.


Biologic Agent, Crohn's Disease, Drug Therapy, Epidemiology, Infection, therapeutic use, Ulcerative Colitis

Read More